Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP860257.RAyxPkq8UYhzAq7jNY7defqOEwgDmi5As6dnYQ08oK7yI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP860257.RAyxPkq8UYhzAq7jNY7defqOEwgDmi5As6dnYQ08oK7yI130_assertion type Assertion NP860257.RAyxPkq8UYhzAq7jNY7defqOEwgDmi5As6dnYQ08oK7yI130_head.
- NP860257.RAyxPkq8UYhzAq7jNY7defqOEwgDmi5As6dnYQ08oK7yI130_assertion wasGeneratedBy ECO_0000203 NP860257.RAyxPkq8UYhzAq7jNY7defqOEwgDmi5As6dnYQ08oK7yI130_provenance.
- NP860257.RAyxPkq8UYhzAq7jNY7defqOEwgDmi5As6dnYQ08oK7yI130_assertion wasDerivedFrom befree-20150227 NP860257.RAyxPkq8UYhzAq7jNY7defqOEwgDmi5As6dnYQ08oK7yI130_provenance.
- NP860257.RAyxPkq8UYhzAq7jNY7defqOEwgDmi5As6dnYQ08oK7yI130_assertion SIO_000772 21715317 NP860257.RAyxPkq8UYhzAq7jNY7defqOEwgDmi5As6dnYQ08oK7yI130_provenance.
- NP860257.RAyxPkq8UYhzAq7jNY7defqOEwgDmi5As6dnYQ08oK7yI130_assertion evidence source_evidence_literature NP860257.RAyxPkq8UYhzAq7jNY7defqOEwgDmi5As6dnYQ08oK7yI130_provenance.
- NP860257.RAyxPkq8UYhzAq7jNY7defqOEwgDmi5As6dnYQ08oK7yI130_assertion description "[In the B-cell lineage, CD160 is a tumor-specific antigen known to mediate cellular activation signals in CLL, and is a novel target for therapeutic manipulation and monitoring of minimal residual disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP860257.RAyxPkq8UYhzAq7jNY7defqOEwgDmi5As6dnYQ08oK7yI130_provenance.